Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000244574

Medchemexpress LLC Brivanib | 649735-46-6 | MFCD13194684 | 99.5% | 370.38 g/mol | C19H19FN4O3 | 50 MG
SDP

Catalog No. 5000244574
Encompass_Preferred

Brivanib is an ATP-competitive inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) supplied for research and analytical applications. It inhibits VEGFR2 with an IC50 of approximately 25 nM and shows activity against related kinases.

  • ATP-competitive VEGFR2 inhibitor (IC50 ≈ 25 nM).
  • Moderate activity against VEGFR-1 and FGFR-1; markedly less active versus PDGFR.
  • Supplied as a solid powder with high purity (~99.5%).
  • Suitable for biochemical and cellular research applications.
  • Stable when stored under recommended conditions for powder and solutions.

Catalog No. 50-002-44574 Supplier Medchemexpress LLC Supplier No. HY1033750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Brivanib is an ATP-competitive inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) supplied for research and analytical applications. It inhibits VEGFR2 with an IC50 of approximately 25 nM and shows activity against related kinases.

  • ATP-competitive VEGFR2 inhibitor (IC50 ≈ 25 nM).
  • Moderate activity against VEGFR-1 and FGFR-1; markedly less active versus PDGFR.
  • Supplied as a solid powder with high purity (~99.5%).
  • Suitable for biochemical and cellular research applications.
  • Stable when stored under recommended conditions for powder and solutions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.